Title,Authors,Platform,Cited_url,Cited_count,Year
Comprehensive genomic characterization defines human glioblastoma genes and core pathways,Cancer Genome Atlas Research Network,"Nature 455 (7216), 1061",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9611756957194261872,4837,2008
Integrated genomic analyses of ovarian carcinoma,Cancer Genome Atlas Research Network,"Nature 474 (7353), 609",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17194858235368681027,3884,2011
Mutations of the VHL tumour suppressor gene in renal carcinoma,"J Gnarra, K Toryz, Y Weng, L Schmidt, MH Weiz, H Liz, F Latif, S Liu, ...","Nature Genetics 7, 85-90","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9542093467084163366,18165367638543826214",1749,1994
Gene expression profiling identifies clinically relevant subtypes of prostate cancer,"J Lapointe, C Li, JP Higgins, M Van De Rijn, E Bair, K Montgomery, ...","Proceedings of the National Academy of Sciences 101 (3), 811-816",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14359175951477560018,1342,2004
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis,"WH Lee, RA Morton, JI Epstein, JD Brooks, PA Campbell, GS Bova, ...","Proceedings of the National Academy of Sciences 91 (24), 11733-11737","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3062137185817230743,722812998230089923",932,1994
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors,"JM Sperger, X Chen, JS Draper, JE Antosiewicz, CH Chon, SB Jones, ...","Proceedings of the National Academy of Sciences 100 (23), 13350-13355",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17868136295098484958,714,2003
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer,"CR King, JD Brooks, H Gill, JC Presti Jr","International Journal of Radiation Oncology* Biology* Physics 82 (2), 877-882",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5553216257414876187,353,2012
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.,"JD Brooks, M Weinstein, X Lin, Y Sun, SS Pin, GS Bova, JI Epstein, ...","Cancer Epidemiology, Biomarkers and Prevention 7 (6), 531-536",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12707773591918517406,347,1998
Potent induction of phase 2 enzymes in human prostate cells by sulforaphane,"JD Brooks, VG Paton, G Vidanes","Cancer Epidemiology, Biomarkers and Prevention 10 (9), 949-954",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5731650409625223498,336,2001
Comparison of open and endourologic approaches to the obstructed ureteropelvic junction,"JD Brooks, LR Kavoussi, GM Preminger, WW Schuessler, RG Moore","Urology 46 (6), 791-795","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8004577854712743995,1953565102614584161",327,1995
Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial,"CR King, JD Brooks, H Gill, T Pawlicki, C Cotrutz, JC Presti Jr","International Journal of Radiation Oncology* Biology* Physics 73 (4), 1043-1048",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1994946623221912272,317,2009
Plasma selenium level before diagnosis and the risk of prostate cancer development,"JD Brooks, EJ Metter, DW Chan, LJ Sokoll, P Landis, WG Nelson, ...","Journal of Urology 166 (6), 2034-2038","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7951091650682615909,2975277287378215290",301,2001
A transcriptional profile of aging in the human kidney,"GEJ Rodwell, R Sonu, JM Zahn, J Lund, J Wilhelmy, L Wang, W Xiao, ...","PLoS Biology 2 (12), e427",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3261753122790363516,299,2004
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis,"J Lapointe, C Li, CP Giacomini, K Salari, S Huang, P Wang, M Ferrari, ...","Cancer Research 67 (18), 8504-8510",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9753215801638459720,296,2007
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray,"JPT Higgins, R Shinghal, H Gill, JH Reese, M Terris, RJ Cohen, M Fero, ...","American Journal of Pathology 162 (3), 925-932","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7087633901036342140,8084281797896855060",269,2003
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells,"X Lin, M Tascilar, WH Lee, WJ Vles, BH Lee, R Veeraswamy, K Asgari, ...","American Journal of Pathology 159, 1815-1826","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10310367156654533673,320928990299137489",267,2001
Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns,"AR Brannon, A Reddy, M Seiler, A Arreola, DT Moore, RS Pruthi, ...","Genes & Cancer 1 (2), 152-163","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9738293799700944660,9237621978220626671",233,2010
Gene expression profiling predicts survival in conventional renal cell carcinoma,"H Zhao, B Ljungberg, K Grankvist, T Rasmuson, R Tibshirani, JD Brooks","PLoS Medicine 3 (1), e13","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18434948957740997021,10630187503717992330",225,2006
Transcriptional programs activated by exposure of human prostate cancer cells to androgen,"SE DePrimo, M Diehn, JB Nelson, RE Reiter, J Matese, M Fero, ...","Genome Biology 3 (7), research0032. 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=980641917331006961,224,2002
Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape,"K Day, LL Waite, A Thalacker-Mercer, A West, MM Bamman, JD Brooks, ...","Genome Biology 14 (9), R102",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3978952620275710175,204,2013
Anatomy of the lower urinary tract and male genitalia,JD Brooks,Campbell-walsh urology,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16805684757187237413,3842327511116089354,17014832339085540478",200,2007
DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer,"Y Kobayashi, DM Absher, ZG Gulzar, SR Young, JK McKenney, DM Peehl, ...","Genome Research 21 (7), 1017-1027",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14111408689508432677,198,2011
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray,"JPT Higgins, G Kaygusuz, L Wang, K Montgomery, V Mason, SX Zhu, ...","American Journal of Surgical Pathology 31 (5), 673-680","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13182559261230048288,6699521670527945740",188,2007
Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer,"JB Nelson, WH Lee, SH Nguyen, DF Jarrard, JD Brooks, SR Magnuson, ...","Cancer Research 57 (1), 35-37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3000471096931545668,180,1997
An uncertain role for p53 gene alterations in human prostate cancers,"JD Brooks, GS Bova, CM Ewing, S Piantadosi, BS Carter, JC Robinson, ...","Cancer Research 56, 3814-3822","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2335718842166783179,5710028642138425587",179,1996
Urinary TMPRSS2: ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study,"DW Lin, LF Newcomb, EC Brown, JD Brooks, PR Carroll, Z Feng, ...","Clinical Cancer Research 19 (9), 2442-2450","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15409618747107620862,6433055324113632079",147,2013
A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis,"J Lapointe, YH Kim, MA Miller, C Li, G Kaygusuz, M van de Rijn, ...","Modern Pathology 20 (4), 467-473",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16915278950684362478,143,2007
Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas,"JD Brooks, GS Bova, WB Isaacs","Prostate 26 (1), 35-39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12629743238314882834,141,1995
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer,"H Kim, J Lapointe, G Kaygusuz, DE Ong, C Li, M van de Rijn, JD Brooks, ...","Cancer Research 65 (18), 8118-8124",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4078017636672394289,138,2005
Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays,"AV Krishnan, R Shinghal, N Raghavachari, JD Brooks, DM Peehl, ...","Prostate 59 (3), 243-251",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8720678979346638689,137,2004
Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells,"H Zhao, ML Whitfield, T Xu, D Botstein, JD Brooks","Molecular Biology of the Cell 15 (2), 506-519",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2420994011796209027,131,2004
Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells,"SR Schwarze, SE DePrimo, LM Grabert, VX Fu, JD Brooks, DF Jarrard","Journal of Biological Chemistry 277 (17), 14877-14883",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1114157619467073055,125,2002
Preneoplastic prostate lesions: an opportunity for prostate cancer prevention,"WG Nelson, AM De Marzo, TL Deweese, X Lin, JD Brooks, MJ Putzi, ...","Annals of the New York Academy of Sciences 952 (1), 135-144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4908621070108650560,125,2001
"Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the mouse striatum","GA Ricaurte, JW Langston, LE DeLanney, I Irwin, JD Brooks","Neuroscience Letters 59 (3), 259-264",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5660087080702251308,125,1985
Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors,"M Makos, BD Nelkin, RE Reiter, JR Gnarra, J Brooks, W Isaacs, ...","Cancer Research 53 (12), 2719-2722",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1584613758804489883,121,1993
mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer,"GM Cann, ZG Gulzar, S Cooper, R Li, S Luo, M Tat, S Stuart, G Schroth, ...","PLoS ONE 7 (11), e49144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14364252951211946026,115,2012
Translational genomics: the challenge of developing cancer biomarkers,JD Brooks,"Genome Research 22 (2), 183-187",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14929955781978903898,113,2012
"Molecular activity of 1, 25-dihydroxyvitamin D 3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis","DM Peehl, R Shinghal, L Nonn, E Seto, AV Krishnan, JD Brooks, ...","Journal of Steroid Biochemistry and Molecular Biology 92 (3), 131-141",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11828138830956259540,113,2004
GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.,"JC Tchou, X Lin, D Freije, WB Isaacs, JD Brooks, A Rashid, AM De Marzo, ...","International Journal of Oncology 16 (4), 663-739",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8798582702544809094,112,2000
Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?,"CR King, JC Presti Jr, H Gill, J Brooks, SL Hancock","International Journal of Radiation Oncology* Biology* Physics 59 (2), 341-347",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13926383245398175045,105,2004
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy,"DA Patel, JC Presti Jr, JE McNeal, H Gill, JD Brooks, CR King","Journal of Clinical Oncology 23 (25), 6157-6162",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13186571490143814161,104,2005
Gene expression in the normal adult human kidney assessed by complementary DNA microarray,"JPT Higgins, L Wang, N Kambham, K Montgomery, V Mason, ...","Molecular Biology of the Cell 15 (2), 649-656","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4452904782946707326,9522529723130445299",103,2004
Molecular biology of prostate cancer,"WB Isaacs, GS Bova, RA Morton, MJ Bussemakers, JD Brooks, CM Ewing","Seminars in Oncology 21 (5), 514-521","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11506950615133300986,5434113840861001219",100,1994
Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era,"SL Conti, IC Thomas, JC Hagedorn, BI Chung, GM Chertow, TH Wagner, ...","International Journal of Cancer 134 (9), 2245-2252",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15221832359337050639,98,2014
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness,"S Huang, ZG Gulzar, K Salari, J Lapointe, JD Brooks, JR Pollack","Oncogene 31 (37), 4164",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6157412082567296151,98,2012
Resveratrol-induced gene expression profiles in human prostate cancer cells,"SB Jones, SE DePrimo, ML Whitfield, JD Brooks","Cancer Epidemiology, Biomarkers and Prevention 14 (3), 596-604",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13667198655211429472,98,2005
Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney,"M Schoenberg, JD Brooks, FF Marshall, JI Epstein, WB Isaacs, P Cairns, ...","Genes, Chromosomes and Cancer 12 (1), 76-80",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14876685490009886970,92,1995
Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability,"SB Chernikova, OV Razorenova, JP Higgins, BJ Sishc, M Nicolau, ...","Cancer Research 72 (8), 2111-2119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1008755366025168474,91,2012
"Outcomes of active surveillance for clinically localized prostate cancer in the prospective, multi-institutional Canary PASS cohort","LF Newcomb, IM Thompson, HD Boyer, JD Brooks, PR Carroll, ...","Journal of Urology 195 (2), 313-320",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18026607345896541299,88,2016
Male pelvic anatomy reconstructed from the visible human data set,"JD Brooks, W Chao, J Kerr","Journal of Urology 159 (3), 868-872",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11032397516827210801,88,1998
Increased risk of cancer in infertile men: analysis of US claims data,"ML Eisenberg, S Li, JD Brooks, MR Cullen, LC Baker","Journal of Urology 193 (5), 1596-1601",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11479090934126339711,81,2015
The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study,"JK McKenney, J Simko, M Bonham, LD True, D Troyer, S Hawley, ...","Journal of Urology 186 (2), 465-469",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12187812431932548318,77,2011
Genome‐wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines,"H Zhao, Y Kim, P Wang, J Lapointe, R Tibshirani, JR Pollack, JD Brooks","Prostate 63 (2), 187-197",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3922114474714117408,73,2005
Molecular biology of prostate cancer progression,"WB Isaacs, GS Bova, RA Morton, MJG Bussemakers, JD Brooks, ...","Cancer Surveys 23, 19-19",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17997909267707775098,70,1995
Utilization of renal mass biopsy in patients with renal cell carcinoma,"JT Leppert, J Hanley, TH Wagner, BI Chung, S Srinivas, GM Chertow, ...","Urology 83 (4), 774-780","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9650691596413429779,16134700753758696325",68,2014
Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1,"ZG Gulzar, JK McKenney, JD Brooks","Oncogene 32 (1), 70-77",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10547504839205897938,66,2013
Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation,"CD Gardner, B Oelrich, JP Liu, D Feldman, AA Franke, JD Brooks","Prostate 69 (7), 719-726",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1704053167650513472,66,2009
Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder,"LB Jacobs, JD Brooks, JI Epstein","Human Pathology 28 (10), 1152-1157",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5072114552210031258,66,1997
The impact of robotic surgery on the surgical management of prostate cancer in the USA,"SL Chang, AS Kibel, JD Brooks, BI Chung","BJU International 115 (6), 929-936",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14725678980247995882,64,2015
A promoting role of androgen receptor in androgen-sensitive and-insensitive prostate cancer cells,"TH Li, H Zhao, Y Peng, J Beliakoff, JD Brooks, Z Sun","Nucleic Acids Research 35 (8), 2767-2776",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15125746296712500893,63,2007
Endothelin-1 promotes cell survival in renal cell carcinoma through the ET A receptor,"BR Pflug, H Zheng, MS Udan, JM D'Antonio, FF Marshall, JD Brooks, ...","Cancer Letters 246 (1), 139-148",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15230341875963760990,63,2007
Polymorphisms in the androgen receptor and type II 5α‐reductase genes and prostate cancer prognosis,"A Shibata, MI Garcia, I Cheng, TA Stamey, JE McNeal, JD Brooks, ...","Prostate 52 (4), 269-278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5910870690602177703,63,2002
Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients,"S Swami, AV Krishnan, J Moreno, RS Bhattacharyya, C Gardner, ...","International Journal of Cancer 124 (9), 2050-2059",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15619015766263320993,62,2009
Reg IV: a promising marker of hormone refractory metastatic prostate cancer,"Z Gu, MA Rubin, Y Yang, SE Deprimo, H Zhao, S Horvath, JD Brooks, ...","Clinical Cancer Research 11 (6), 2237-2243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10356957668861155785,61,2005
Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids,"S Banerjee, RN Zare, RJ Tibshirani, CA Kunder, R Nolley, R Fan, ...","Proceedings of the National Academy of Sciences 114 (13), 3334-3339",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8789782619193614146,57,2017
Anatomy of the lower urinary tract and male genitalia,"BI Chung, G Sommer, JD Brooks","Campbell-Walsh Urology 10, 33-72",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7721106062716974974,57,2012
Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues,"H Zhao, CF Ramos, JD Brooks, DM Peehl","Journal of Cellular Physiology 210 (1), 111-121",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16300540179830082223,56,2007
"Differential gene-expression patterns in genital fibroblasts of normal males and 46, XY females with androgen insensitivity syndrome: evidence for early programming involving …","PM Holterhus, O Hiort, J Demeter, PO Brown, JD Brooks","Genome Biology 4 (6), R37",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4385991962363319885,56,2003
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository,"LF Newcomb, JD Brooks, PR Carroll, Z Feng, ME Gleave, PS Nelson, ...","Urology 75 (2), 407-413",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8582124835118150053,55,2010
Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists,"GA Sonn, RE Fan, P Ghanouni, NN Wang, JD Brooks, AM Loening, ...",European Urology Focus,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13882553951069538075,54,2017
Tumor suppressor gene allelic loss in human renal cancers,"JD Brooks, GS Bova, FF Marshall, WB Isaacs","The Journal of urology 150 (4), 1278-1283",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14834645945432133417,54,1993
Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells,"S Bhamre, D Sahoo, R Tibshirani, DL Dill, JD Brooks","Prostate 69 (2), 181-190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12535009136005094290,52,2009
Histologic grading of prostatic adenocarcinoma can be further optimized: analysis of the relative prognostic strength of individual architectural patterns in 1275 patients from …,"JK McKenney, W Wei, S Hawley, H Auman, LF Newcomb, HD Boyer, ...","American Journal of Surgical Pathology 40 (11), 1439-1456",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15181864123429000376,51,2016
Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription,"JH Bebermeier, JD Brooks, SE DePrimo, R Werner, U Deppe, J Demeter, ...","Journal of Molecular Medicine 84 (11), 919-931","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13102380558051257019,6241338001518377297",51,2006
Microarray analysis in prostate cancer research,JD Brooks,"Current opinion in urology 12 (5), 395-399",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5862900556879635299,51,2002
Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population,"JC Presti, U Lee, JD Brooks, MK Terris","Journal of Urology 171 (6), 2199-2202","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2021617127646387779,5391438371666080745",49,2004
A multicenter study shows ,"DA Troyer, T Jamaspishvili, W Wei, Z Feng, J Good, S Hawley, L Fazli, ...","The Prostate 75 (11), 1206-1215",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11594568604581653269,48,2015
Molecular genetics and chromosomal alterations in prostate cancer,"WB Isaacs, GS Bova, RA Morton, MJG Bussemakers, JD Brooks, ...","Cancer 75 (S7), 2004-2012",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1702626854466462672,47,1995
Tubularized neourethra following radical retropubic prostatectomy,"MS Steiner, AL Burnett, JD Brooks, CB Brendler, RE Stutzman, HB Carter","The Journal of urology 150 (2 Part 1), 407-409",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10145092524768859431,47,1993
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with ,"TL Lotan, W Wei, O Ludkovski, CL Morais, LB Guedes, T Jamaspishvili, ...","Modern Pathology 29 (8), 904",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11563392924295690772,46,2016
Genetic alterations in prostate cancer,"WB Isaacs, GS Bova, RA Morton, MJG Bussemakers, JD Brooks, ...","Cold Spring Harbor Symposia on Quantitative Biology 59, 653-659",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5706759014826367625,46,1994
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature,"J Lapointe, S Malhotra, JP Higgins, E Bair, M Thompson, K Salari, ...","American Journal of Surgical Pathology 32 (2), 205-209",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17418737025220085602,45,2008
Evaluating the four kallikrein panel of the 4kscore for prediction of high-grade prostate cancer in men in the canary prostate active surveillance study,"DW Lin, LF Newcomb, MD Brown, DD Sjoberg, Y Dong, JD Brooks, ...","European Urology 72 (3), 448-454","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3153340585383287702,13517392770340110031",43,2017
PTEN loss as determined by clinical-grade immunohistochemistry assay is associated with worse recurrence-free survival in prostate cancer,"TL Lotan, W Wei, CL Morais, ST Hawley, L Fazli, A Hurtado-Coll, D Troyer, ...","European Urology Focus 2 (2), 180-188","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4464467046485009371,13033709203256922621",43,2016
"The radiogenomic risk score: construction of a prognostic quantitative, noninvasive image-based molecular assay for renal cell carcinoma","N Jamshidi, E Jonasch, M Zapala, RL Korn, L Aganovic, H Zhao, ...","Radiology 277 (1), 114-123",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14297600697437702919,43,2015
Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases,"AR Sangoi, J Karamchandani, B Lane, JP Higgins, RV Rouse, JD Brooks, ...","Modern Pathology 24 (3), 425",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16764865789085500177,43,2011
Modest induction of phase 2 enzyme activity in the F-344 rat prostate,"SB Jones, JD Brooks","BMC Cancer 6 (1), 62",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4154131043101348558,43,2006
Precision medicine in active surveillance for prostate cancer: development of the canary–early detection research network active surveillance biopsy risk calculator,"DP Ankerst, J Xia, IM Thompson, J Hoefler, LF Newcomb, JD Brooks, ...","European Urology 68 (6), 1083-1088",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10150652779578218523,41,2015
Microarray data mining for potential selenium targets in chemoprevention of prostate cancer,"H Zhang, Y Dong, H Zhao, JD Brooks, L Hawthorn, N Nowak, JR Marshall, ...","Cancer Genomics-Proteomics 2 (2), 97-113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17842195543165528773,39,2005
A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer,"S Malhotra, J Lapointe, K Salari, JP Higgins, M Ferrari, K Montgomery, ...","PLoS One 6 (5), e20293",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9386260373148325065,38,2011
Prognostic significance of prostate cancer originating from the transition zone,"CR King, M Ferrari, JD Brooks","Urologic Oncology: Seminars and Original Investigations 27 (6), 592-597",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15206168040810168933,38,2009
Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome,"M Appari, R Werner, L Wünsch, G Cario, J Demeter, O Hiort, F Riepe, ...","Journal of Molecular Medicine 87 (6), 623",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7891266635040905476,38,2009
CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma,"AA Williams, JPT Higgins, H Zhao, B Ljungberg, JD Brooks","BMC Clinical Pathology 9 (1), 9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5886831362027040412,37,2009
Anatomy of the rectourethralis muscle,"JD Brooks, SE Eggener, WM Chao","European Urology 41 (1), 94-100",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1570638247953359942,37,2002
Novel fusion transcripts associate with progressive prostate cancer,"PY Yan, Y Ding, Z Chen, S Liu, A Michalopoulos, R Chen, ZG Gulzar, ...","American Journal of Pathology 184 (10), 2840-2849",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15101615747563980922,36,2014
Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables,"MK Ferrari, JE McNeal, SM Malhotra, JD Brooks","Urology 64 (4), 749-753",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11975668930938406206,35,2004
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma,"BN Lasseigne, TC Burwell, MA Patil, DM Absher, JD Brooks, RM Myers","BMC Medicine 12 (1), 235",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2922856013215434727,32,2014
"The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic …","CM Quick, N Gokden, AR Sangoi, JD Brooks, JK McKenney","Human Pathology 41 (8), 1145-1149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12423610491550053668,32,2010
Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology,"JP Higgins, JK McKenney, JD Brooks, P Argani, JI Epstein","Human Pathology 40 (4), 456-463",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16660300939167541927,32,2009
Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen …,"PM Holterhus, U Deppe, R Werner, A Richter-Unruh, JH Bebermeier, ...","BMC Genomics 8 (1), 376",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10218756967822089265,32,2007
Biologic differences between peripheral and transition zone prostate cancer,"JJ Lee, IC Thomas, R Nolley, M Ferrari, JD Brooks, JT Leppert","The Prostate 75 (2), 183-190",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8058589259226915690,31,2015
Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillance,"J Busch, A Magheli, N Leva, M Ferrari, J Kramer, C Klopf, ...","BJU International 114 (4), 517-521",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7346706886182181177,31,2014
Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays,"JPT Higgins, K Montgomery, L Wang, E Domanay, RA Warnke, JD Brooks, ...","American Journal of Surgical Pathology 27 (1), 58-64",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=96961000241635533,31,2003
Selenomethionine induced transcriptional programs in human prostate cancer cells,"H Zhao, JD Brooks","Journal of Urology 177 (2), 743-750",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16288981840486602613,30,2007
Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro,"JD Brooks, MF Goldberg, LA Nelson, D Wu, WG Nelson","Cancer Epidemiology, Biomarkers and Prevention 11 (9), 868-875",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16759159485037336832,30,2002
The Swedish prostate cancer paradox,"PC Walsh, JD Brooks","JAMA 277 (6), 497-498",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=799297989663972086,30,1997
Prostate cancer risk profiles of Asian-American men: disentangling the effects of immigration status and race/ethnicity,"DY Lichtensztajn, SL Gomez, W Sieh, BI Chung, I Cheng, JD Brooks","Journal of Urology 191 (4), 952-956",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4999778589022565871,29,2014
Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy,"R Shinghal, C Yemoto, JE McNeal, JD Brooks","Urology 61 (2), 380-385",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16600319477862712810,29,2003
Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of> 1000 prostatectomies,"MS Tretiakova, W Wei, HD Boyer, LF Newcomb, S Hawley, H Auman, ...","Prostate Cancer and Prostatic Diseases 19 (3), 264-270",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5303490500581403843,28,2016
Identification of candidate prostate cancer genes through comparative expression‐profiling of seminal vesicle,"M Thompson, J Lapointe, YL Choi, DE Ong, JP Higgins, JD Brooks, ...","The Prostate 68 (11), 1248-1256",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3663767453905313988,28,2008
Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy,"KL Lee, JB Marotte, MK Ferrari, JE McNeal, JD Brooks, JC Presti Jr","Urology 65 (2), 311-315",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8982740551452356775,28,2005
Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy,"CR King, JC Presti, JD Brooks, H Gill, MT Spiotto","International Journal of Radiation Oncology* Biology* Physics 70 (5), 1472-1477",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4578728318457857709,27,2008
Nationwide prevalence of lymph node metastases in Gleason score 3+ 3= 6 prostate cancer,"JJ Liu, DY Lichtensztajn, SL Gomez, W Sieh, BI Chung, I Cheng, ...","Pathology 46 (4), 306-310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=842399320422288880,26,2014
Increased expression of ,"Z Chen, ZG Gulzar, CA St. Hill, B Walcheck, JD Brooks","The Prostate 74 (10), 1059-1067",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2640969986637747508,25,2014
Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival,"BI Chung, TV Tarin, M Ferrari, JD Brooks","Urologic Oncology: Seminars and Original Investigations 29 (3), 314-318",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16872132323537695325,25,2011
Juvenile posttraumatic high-flow priapism: current management dilemmas,"JB Marotte, JD Brooks, D Sze, WA Kennedy","Journal of Pediatric Surgery 40 (4), E25-E28",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7246955156632608882,25,2005
Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes,"PM Holterhus, JH Bebermeier, R Werner, J Demeter, A Richter-Unruh, ...","BMC Genomics 10 (1), 292",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17056402674402629647,24,2009
Application of genomic technologies to human prostate cancer,"S Li, S Bhamre, J Lapointe, JR Pollack, JD Brooks","Omics: a Journal of Integrative Biology 10 (3), 261-275",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16527200146029594078,23,2006
GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress,"OY Mian, MH Khattab, M Hedayati, J Coulter, B Abubaker‐Sharif, ...","The Prostate 76 (2), 199-206",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17767687183788714192,22,2016
Evaluation of ERG and SPINK1 by immunohistochemical staining and clinicopathological outcomes in a multi-institutional radical prostatectomy cohort of 1067 patients,"JD Brooks, W Wei, S Hawley, H Auman, L Newcomb, H Boyer, L Fazli, ...","PLoS One 10 (7), e0132343",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7980590173169474143,22,2015
Smoking and adverse outcomes at radical prostatectomy,"TC Ngo, JJ Lee, JD Brooks, R Nolley, M Ferrari, JC Presti Jr","Urologic Oncology: Seminars and Original Investigations 31 (6), 749-754",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3008181947198240408,22,2013
The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial,"N Jamshidi, E Jonasch, M Zapala, RL Korn, JD Brooks, B Ljungberg, ...","European Radiology 26 (8), 2798-2807",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14443499707259144389,21,2016
Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas,"H Zhao, Z Ma, R Tibshirani, JPT Higgins, B Ljungberg, JD Brooks","PLoS ONE 4 (6), e6039",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6922615496644737148,21,2009
Role of cytologic criteria in the histologic diagnosis of Gleason grade 1 prostatic adenocarcinoma,"JE McNeal, RJ Cohen, JD Brooks","Human Pathology 32 (4), 441-446",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7810895615047286432,21,2001
Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns,"MK Kirby, RC Ramaker, BS Roberts, BN Lasseigne, DS Gunther, ...","BMC Cancer 17 (1), 273",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3647317632030471875,20,2017
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray,"S Hawley, L Fazli, JK McKenney, J Simko, D Troyer, M Nicolas, ...","Advances in Anatomic Pathology 20 (1), 39",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9840390315901228138,20,2013
Small prostate size and high grade disease—biology or artifact?,"JJ Liu, JD Brooks, M Ferrari, R Nolley, JC Presti","Journal of Urology 185 (6), 2108-2111","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6991955091817407951,4722515113311800081",20,2011
Time trends in pathologic features of radical prostatectomy—impact of family history,"JB Marotte, MK Ferrari, JE McNeal, JD Brooks, JC Presti Jr","Urologic Oncology: Seminars and Original Investigations 22 (3), 169-173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11764830133334074447,20,2004
Molecular targets of doxazosin in human prostatic stromal cells,"H Zhao, F Lai, L Nonn, JD Brooks, DM Peehl","The Prostate 62 (4), 400-410",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7732926198468429101,19,2005
Biochemical remission after resection of prostate cancer lung metastasis,"DH Chao, JPT Higgins, JD Brooks","Urology 63 (3), 584-585",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2203695360730055606,19,2004
Prevention of prostate cancer,"SE DePrimo, R Shinghal, G Vidanes, JD Brooks","Hematology/Oncology Clinics of North America 15 (3), 445-457",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2991497719151861464,19,2001
NUSAP1 promotes invasion and metastasis of prostate cancer,"CA Gordon, X Gong, D Ganesh, JD Brooks","Oncotarget 8 (18), 29935",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7467969623056724316,18,2017
Methods for registration of magnetic resonance images of ex vivo prostate specimens with histology,"SY Kimm, TV Tarin, JH Lee, B Hu, K Jensen, D Nishimura, JD Brooks","Journal of Magnetic Resonance Imaging 36 (1), 206-212",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=636793125613616574,18,2012
 expression is upregulated by loss of RB1 in prostate cancer cells,"CA Gordon, ZG Gulzar, JD Brooks","The Prostate 75 (5), 517-526",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5460959872124843090,17,2015
"Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent","JD Brooks, V Paton","Prostate Cancer and Prostatic Diseases 2 (suppl 3), 58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1430680372946224096,17,1999
Markers of DNA copy number alteration for improved prognostication in prostate cancer,"JR Pollack, J Lapointe, JD Brooks","US Patent 7,638,278",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2417156742819529366,16,2009
"New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents","ED Williams, JD Brooks","Urology 57 (4), 100-102",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15606487543675375557,15,2001
"Trends in incidence and 5‐year mortality in men with newly diagnosed, metastatic prostate cancer—A population‐based analysis of 2 national cohorts","JT Helgstrand, MA Røder, N Klemann, BG Toft, DY Lichtensztajn, ...","Cancer 124 (14), 2931-2938",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=54420135990739413,14,2018
Incident CKD after radical or partial nephrectomy,"JT Leppert, RW Lamberts, IC Thomas, BI Chung, GA Sonn, EC Skinner, ...","J Am Soc Nephrol 29 (1), 207-216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2604243704737289141,14,2018
Timing of adverse prostate cancer reclassification on first surveillance biopsy: results from the Canary Prostate Cancer Active Surveillance Study,"LC Macleod, WJ Ellis, LF Newcomb, Y Zheng, JD Brooks, PR Carroll, ...","Journal of Urology 197 (4), 1026-1033",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15551390407911883614,14,2017
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi‐Institutional Radical Prostatectomy Cohort,"JD Brooks, W Wei, JR Pollack, RB West, JH Shin, JB Sunwoo, SJ Hawley, ...","The Prostate 76 (15), 1409-1419",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8666995777384225239,14,2016
Evaluation of SF-1 expression in testicular germ cell tumors: a tissue microarray study of 127 cases,"AR Sangoi, JK McKenney, JD Brooks, JP Higgins","Applied Immunohistochemistry & Molecular Morphology 21 (4), 318-321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5669516356348567011,14,2013
Treatment and mortality in men with localized prostate cancer: a population-based study in California,"W Sieh, DY Lichtensztajn, DO Nelson, M Cockburn, DW West, JD Brooks, ...","The Open Prostate Cancer Journal 6, 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6966098530167466509,14,2013
Gene expression changes induced by genistein in the prostate cancer cell line LNCaP,"S Bhamre, D Sahoo, R Tibshirani, DL Dill, JD Brooks","The Open Prostate Cancer Journal 3, 86-98",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13924308373476854547,14,2010
Absence of HinfI Restriction Abnormalities in Renal Oncocytoma Mitochondrial DNA.,"JD Brooks, FF Marshall, and Isaacs, WB, DR Johns","Molecular Urology 3 (1), 1-3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7751774419686838250,14,1999
Length of site‐specific positive surgical margins as a risk factor for biochemical recurrence following radical prostatectomy,"M Hsu, SL Chang, M Ferrari, R Nolley, JC Presti Jr, JD Brooks","International Journal of Urology 18 (4), 272-279",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3540480761219165450,13,2011
Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade,"CR King, JE McNeal, H Gill, JD Brooks, S Srinivas, JC Presti Jr","Urology 67 (6), 1229-1234",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5861998772637863185,13,2006
Overall survival in patients with localized prostate cancer in the US Veterans Health Administration: is PIVOT generalizable?,"PV Barbosa, IC Thomas, S Srinivas, MK Buyyounouski, BI Chung, ...","European Urology 70 (2), 227-230",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14932350308664292913,12,2016
A magnetic bead-based sensor for the quantification of multiple prostate cancer biomarkers,"JV Jokerst, Z Chen, L Xu, R Nolley, E Chang, B Mitchell, JD Brooks, ...","PLoS ONE 10 (9), e0139484",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1049813129912670818,12,2015
Gene expression changes induced by unilateral ureteral obstruction in mice,"B Wu, JD Brooks","Journal of Urology 188 (3), 1033-1041",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17885451925650617415,12,2012
Role of surveillance biopsy with no cancer as a prognostic marker for reclassification: results from the canary prostate active surveillance study,"JT Kearns, AV Faino, LF Newcomb, JD Brooks, PR Carroll, A Dash, ...","European urology 73 (5), 706-712","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18048819193491740812,12121652006099378736",11,2018
Contemporary use of partial nephrectomy: are older patients with impaired kidney function being left behind?,"JT Leppert, HR Mittakanti, IC Thomas, RW Lamberts, GA Sonn, BI Chung, ...","Urology 100, 65-71",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2870971047688056232,11,2017
New paradigms for patient-centered outcomes research in electronic medical records: an example of detecting urinary incontinence following prostatectomy,"T Hernandez-Boussard, S Tamang, D Blayney, J Brooks, N Shah",eGEMs 4 (3),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5556372120436631596,11,2016
Managing localized prostate cancer in the era of prostate‐specific antigen screening,JD Brooks,"Cancer 119 (22), 3906-3909",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11108401203224156051,11,2013
"Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2","BE Howitt, JD Brooks, S Jones, JPT Higgins","Applied Immunohistochemistry & Molecular Morphology 21 (5), 401-407",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10940139653410373395,11,2013
Comprehensive gene expression changes associated with mouse postnatal kidney development,"B Wu, D Sahoo, JD Brooks","Journal of Urology 189 (6), 2385-2390",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13736834726663017581,11,2013
Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence,"M Truong, B Yang, J Wagner, Y Kobayashi, V Rajamanickam, J Brooks, ...","British Journal of Cancer 107 (1), 100-107",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3828293125040261362,11,2012
Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer,"X Gong, Z Siprashvili, O Eminaga, Z Shen, Y Sato, H Kume, Y Homma, ...","Oncotarget 8 (12), 18657",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13034899776034214485,10,2017
Silencing of π‐class glutathione S‐transferase in MDA PCa 2a and MDA PCa 2b cells,"GM Vidanes, V Paton, E Wallen, DM Peehl, N Navone, JD Brooks","The Prostate 51 (4), 225-230",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1840648733018665794,10,2002
The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1- 13C]-ketoisocaproate,"KL Billingsley, JM Park, S Josan, R Hurd, D Mayer, E Spielman-Sun, ...","Magnetic Resonance Imaging 32, 791-795",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13924570329931514879,9,2014
Recommendations for the reporting of surgically resected specimens of renal cell carcinoma,Association of Directors of Anatomic and Surgical Pathology,"American journal of clinical pathology 131 (5), 623-630",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=945436658510930169,9,2009
The impact of tumor volume on outcomes after radical prostatectomy: Implications for prostate cancer screening,"JD Brooks, R Tibshirani, M Ferrari, JC Presti, H Gill, CR King","The Open Prostate Cancer Journal 1, 1-8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4796963612003861341,9,2008
Refractory hematuria from amyloidosis successfully treated by splenectomy,"JF Ma, SE Coutre, MJ Curet, JD Brooks","Urology 67 (5), 1085. e13-1085. e15",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=835422461717954471,9,2006
Architecture and implementation of a clinical research data warehouse for prostate cancer,"MG Seneviratne, T Seto, DW Blayney, JD Brooks, T Hernandez-Boussard",eGEMs 6 (1),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1456568826290188852,8,2018
Multi-lectin affinity chromatography and quantitative proteomic analysis reveal differential glycoform levels between prostate cancer and benign prostatic hyperplasia sera,"SM Totten, R Adusumilli, M Kullolli, C Tanimoto, JD Brooks, P Mallick, ...","Scientific reports 8 (1), 6509",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13933550716944921581,7,2018
Mining electronic health records to extract patient-centered outcomes following prostate cancer treatment,"T Hernandez-Boussard, PD Kourdis, T Seto, M Ferrari, DW Blayney, ...","AMIA Annual Symposium Proceedings 2017, 876",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3876592572659137037,7,2017
"Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases","AR Sangoi, JK McKenney, JD Brooks, JV Bonventre, JP Higgins","Applied Immunohistochemistry & Molecular Morphology 20 (5), 451",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5262596514105947090,7,2012
Partial nephrectomy and caval thrombectomy for renal cell carcinoma in a solitary kidney with an accessory renal vein,"RS Pruthi, SK Angell, JD Brooks, H Gill","BJU International 83 (1), 142-143",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4481027589582511752,7,1999
Allelic loss of the retinoblastoma gene in primary renal and prostate cancer,"JD Brooks, GS Bova, FF Marshall, WB Isaacs","Journal of Urology 149, 376A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1196320843591576272,7,1993
Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes,"MR Cooperberg, JD Brooks, AV Faino, LF Newcomb, JT Kearns, ...",European urology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11770483208528025877,6,2018
A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment,"MA Liss, JM Schenk, AV Faino, LF Newcomb, H Boyer, JD Brooks, ...","Prostate Cancer and Prostatic Diseases 19 (4), 390",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16804023055748209385,6,2016
Accuracy of prostate-specific antigen values in prostate cancer registries.,"HR Mittakanti, IC Thomas, JB Shelton, DV Makarov, TA Skolarus, ...",Journal of clinical oncology: official journal of the American Society of …,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16962756587260346119,6,2016
Laparoscopic management of testicular pain after embolotherapy of varicocele,"JD Brooks, RG Moore, LR Kavoussi","Journal of Endourology 8 (5), 361-363",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15423024370799387468,6,1994
Simultaneous transrectal ultrasound and photoacoustic human prostate imaging,"SR Kothapalli, GA Sonn, JW Choe, A Nikoozadeh, A Bhuyan, KK Park, ...","Science translational medicine 11 (507), eaav2169",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13655814999887909448,5,2019
The research implications of prostate specific antigen registry errors: data from the Veterans Health Administration,"DP Guo, IC Thomas, HR Mittakanti, JB Shelton, DV Makarov, TA Skolarus, ...","The Journal of urology 200 (3), 541-548",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14981762410141001061,5,2018
The role of DNA methylation in renal cell carcinoma,"BN Lasseigne, JD Brooks","Molecular diagnosis & therapy 22 (4), 431-442",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15012161515104784210,5,2018
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer,"D Sahoo, W Wei, H Auman, A Hurtado-Coll, PR Carroll, L Fazli, ...","Oncotarget 9 (5), 6550",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5160580407284834120,5,2018
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study,"O Eminaga, W Wei, SJ Hawley, H Auman, LF Newcomb, J Simko, ...","PLoS ONE 11 (11), e0165236",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2953561603695957678,5,2016
Biallelic methylation of promoter sequences of the glutathione S-transferase-π gene in human prostate cancers,"X Lin, M Tascilar, W Vles, WH Lee, GS Bova, WB Isaacs, JD Brooks, ...","Journal of Urology 157, 343",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12205005569881024746,5,1997
Weakly supervised natural language processing for assessing patient-centered outcome following prostate cancer treatment,"I Banerjee, K Li, M Seneviratne, M Ferrari, T Seto, JD Brooks, DL Rubin, ...","JAMIA open 2 (1), 150-159",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12873084469237763049,4,2019
The CPC risk calculator: a new app to predict prostate-specific antigen recurrence during follow-up after radical prostatectomy,"MA Røder, KD Berg, MD Loft, FB Thomsen, M Ferrari, S Kurbegovic, ...","European urology focus 4 (3), 360-368",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13414595005443797077,4,2018
mp1-17 Pten Status Determination In Prostate Cancer: Comparison Of Ihc And Fish In A Large Multi-center Cohort,"TL Lotan, CL Morais, W Wei, T Jamaspishvili, Z Feng, J McKenney, ...","The Journal of Urology 193 (4), e7-e8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15700305750669315533,4,2015
Methylation Biomarkers for Diagnosis of Prostate Cancer,"GJ Sherlock, JD Brooks, RM Myers, Y Kobayashi, DM Absher","US Patent App. 14/008,480",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18023256498184719838,4,2014
Embryonal Adenoma of Kidney in Adult: Case Report,"EJ Perlman, J Brooks, AH Gordon, CA Griffin, M Schoenberg","Journal of Urology 154 (4), 1473-1474",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=421640918025873329,4,1995
Utilization of prostate cancer quality metrics for research and quality improvement: a structured review,"D Gori, R Dulal, DW Blayney, JD Brooks, MP Fantini, KM McDonald, ...","The Joint Commission Journal on Quality and Patient Safety 45 (3), 217-226",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12817935245718841491,3,2019
Performance of PCA3 and TMPRSS2: ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS),"LF Newcomb, Y Zheng, AV Faino, D Bianchi-Frias, MR Cooperberg, ...","Prostate cancer and prostatic diseases, 1",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10871390526320513770,3,2019
Identification of transcripts associated with renal damage due to ureteral obstruction as candidate urinary biomarkers,"B Wu, X Gong, WA Kennedy, JD Brooks","American Journal of Physiology-Renal Physiology 315 (1), F16-F26",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4131857994239878996,3,2018
Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy,"NN Wang, RE Fan, JT Leppert, P Ghanouni, CA Kunder, JD Brooks, ...","Research and reports in urology 10, 233",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7805495412031336095,3,2018
A natural language processing algorithm to measure quality prostate cancer care.,"T Hernandez-Boussard, P Kourdis, R Dulal, M Ferrari, S Henry, T Seto, ...","Journal of Clinical Oncology 35 (8_suppl), 232-232",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6080949980890575420,3,2017
Frequent promoter methylation of the endothelin B receptor gene EDNRB in human renal tumors,"H Zheng, BR Pflug, FF Marshall, JB Nelson, JD Brooks","Journal of Urology 161 (4S), 137",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8467692673619387521,3,1999
Transitional cell carcinoma of the upper urinary tract,"JD Brooks, FF Marshall","Principles and Practice of Genitourinary Oncology, 337-345",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15144138705138047847,3,1997
Epidemiological and molecular features of prostatic carcinogenesis as clues for new prostate cancer prevention strategies,"JD Brooks, WH Lee, WG Nelson","Canadian Journal of Urology (Suppl) 3 (1), 20-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7164975219410919109,3,1996
Genetic alterations in prostate cancer–prognostic implications,"WB Isaacs, GS Bova, JD Brooks, CM Ewing, RA Morton, JR Robinson","Prognostic Factors in Urological Cancers, 84-92",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7471404867712315670,3,1993
Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis,"LW Middleton, Z Shen, S Varma, AS Pollack, X Gong, S Zhu, C Zhu, ...",JCI insight,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2031177761590378879,2,2019
"Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford …","MD Loft, KD Berg, A Kjaer, P Iversen, M Ferrari, CA Zhang, K Brasso, ...",Clinical Genitourinary Cancer,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7830072187290360207,2,2017
MR-histology correlation in ex-vivo human prostate specimens,"SY Kimm, JH Lee, DG Nishimura, TV Tarin, BS Hu, K Jensen, JD Brooks","ISMRM 17th Scientific meeting & exhibition, Honolulu Hawaii, USA",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17247434373521520396,2,2009
468: Performance of PSA Levels between 4 and 10 NG/ML in the Era of Extended Biopsy Schemes,"JC Presti, JE McNeal, TH Hsu, JD Brooks, H Gill","The Journal of Urology 175 (4), 151-152",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9879308069137181063,2,2006
Chemoprevention of prostate cancer,"JD Brooks, WG Nelson","Prostate Cancer, 365-375",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11971802263789292329,2,2001
UPJ obstruction: Assessing minimally invasive therapies,"RG Moore, JD Brooks","Contemporary Urology 7, 47-61",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13519884808237725969,2,1995
S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma,"Y Xiao, H Zhao, L Tian, R Nolley, AN Diep, A Ernst, KC Fuh, YR Miao, ...","Cancer research 79 (22), 5758-5768",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9110900298843459438,1,2019
Plexus Convolutional Neural Network (PlexusNet): A novel neural network architecture for histologic image analysis,"O Eminaga, M Abbas, C Kunder, AM Loening, J Shen, JD Brooks, ...",arXiv preprint arXiv:1908.09067,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4906986956468972816,1,2019
Comparison of orthogonal NLP methods for clinical phenotyping and assessment of bone scan utilization among prostate cancer patients,"J Coquet, S Bozkurt, KM Kan, MK Ferrari, DW Blayney, JD Brooks, ...","Journal of biomedical informatics 94, 103184",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6487240029077657140,1,2019
Framework for the co-registration of MRI and histology images in prostate cancer patients with radical prostatectomy,"M Rusu, C Kunder, R Fan, P Ghanouni, R West, G Sonn, J Brooks","Medical Imaging 2019: Image Processing 10949, 109491P",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14295052309658708827,1,2019
Distribution of global health measures from routinely collected PROMIS surveys in patients with breast cancer or prostate cancer,"MG Seneviratne, S Bozkurt, MI Patel, T Seto, JD Brooks, DW Blayney, ...","Cancer 125 (6), 943-951",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2571459817069472974,1,2019
Vasectomy and the risk of prostate cancer in a prospective US Cohort: Data from the NIH‐AARP Diet and Health Study,"MT Davenport, CA Zhang, JT Leppert, JD Brooks, ML Eisenberg","Andrology 7 (2), 178-183",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=475401035607514682,1,2019
Multiregion Quantification of Extracellular Signal-regulated Kinase Activity in Renal Cell Carcinoma,"CR Hoerner, R Massoudi, TJ Metzner, L Stell, JJ O’Rourke, CS Kong, ...",European Urology Oncology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6298748931916370490,1,2018
Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active …,"JT Kearns, AV Faino, JM Schenk, LF Newcomb, JD Brooks, PR Carroll, ...",The Journal of urology,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12588932940391498011,1,2018
Male infertility is associated with altered treatment course of men with cancer,"O Eminaga, S Li, LC Baker, JD Brooks, ML Eisenberg","Andrology 6 (3), 408-413","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1029590916853636675,6897559959775865183",1,2018
An Automated Feature Engineering for Digital Rectal Examination Documentation using Natural Language Processing,"S Bozkurt, JI Park, KM Kan, M Ferrari, DL Rubin, JD Brooks, ...","AMIA Annual Symposium Proceedings 2018, 288",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14870429795158892657,1,2018
MP04-15 VASECTOMY AND THE RISK OF PROSTATE CANCER IN A PROSPECTIVE US COHORT: ANALYSIS IN THE PRESENCE OF SELECTION BIAS,"M Davenport, S Li, J Brooks, M Cullen, M Eisenberg","Journal of Urology 195 (4), e34",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9842273188008650083,1,2016
Increased proliferative rate and PTEN loss in prostate cancer are correlated and both associated with risk of recurrence in multivariate models,"MS Tretiakova, W Wei, CL Morais, Z Feng, JK McKenney, J Simko, ...","LABORATORY INVESTIGATION 96, 267A-267A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17146642235059013683,1,2016
nano-scale proteomic profiling to define diagnostic signatures and biomarkers of therapeutic activity in patients with Rcc: 24,"JT Leppert, AC Fan, T Metzner, JE Liliental, L Xu, AE Thong, C Yost, ...","Bju International 112, 14",,1,2013
Epigenetic changes in histologically normal prostate tissues,JD Brooks,"Journal of Urology 189 (6), 2020-2021",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1189475417057878148,1,2013
Nano-scale proteomic profiles of response to targeted therapy in patients with RCC.,"AC Fan, J Leppert, JE Liliental, L Xu, TJ Metzner, E Shroff, A Yaghi, ...","Cancer Research 73 (8 Supplement), 2283-2283",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14301686343108055958,1,2013
Nanoscale proteomic profiling to define diagnostic signatures and biomarkers of therapeutic activity in patients with RCC.,"AC Fan, J Leppert, JE Liliental, L Xu, AE Thong, C Yost, A Yaghi, ...","Journal of Clinical Oncology 31 (6_suppl), 432-432",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1883973300285153047,1,2013
"Use of nano-immuno assay to generate rapid, quantitative nanoscale proteomic profiling of the hypoxia pathway in renal cell carcinoma clinical specimens.","AC Fan, P Banerjee, J Leppert, LC Harshman, C Sabatti, JD Brooks, ...","Journal of Clinical Oncology 30 (15_suppl), 10513-10513",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18020406543966067180,1,2012
correlation Of Histologic Sections And Magnetic Resonance Imaging In Ex-vivo Human Prostate Specimens: 2158,"S Kimm, TV Tarin, JH Lee, DG Nishimura, KC Jensen, BS Hu, DS Lee, ...","The Journal of Urology 181 (4), 783",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1489632158999937955,1,2009
Microarray analysis and prostate cancer research,"SE DePrimo, JD Brooks",CTCL. Comsult. com,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5822777621427061978,1,2000
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study (PASS),"JM Schenk, LF Newcomb, Y Zheng, AV Faino, K Zhu, YA Nyame, ...","The Journal of urology, 10.1097/JU. 0000000000000621",,0,2019
Machine Learning Approaches for Extracting Stage from Pathology Reports in Prostate Cancer.,"R Lenain, MG Seneviratne, S Bozkurt, DW Blayney, JD Brooks, ...","Studies in health technology and informatics 264, 1522-1523",,0,2019
early detection of unilateral ureteral obstruction by desorption electrospray ionization mass spectrometry,"S Banerjee, ACY Wong, X Yan, B Wu, H Zhao, RJ Tibshirani, RN Zare, ...","Scientific reports 9 (1), 1-10",,0,2019
Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis,"G Kristensen, KD Berg, BG Toft, HV Stroomberg, R Nolley, JD Brooks, ...","Journal of clinical pathology, jclinpath-2019-205940",,0,2019
PSA Testing Use and Prostate Cancer Diagnostic Stage After the 2012 US Preventive Services Task Force Guideline Changes,"CJ Magnani, K Li, T Seto, KM McDonald, DW Blayney, JD Brooks, ...","Journal of the National Comprehensive Cancer Network 17 (7), 795-803",,0,2019
Is it possible to automatically assess pretreatment digital rectal examination documentation using natural language processing? A single-centre retrospective study,"S Bozkurt, KM Kan, MK Ferrari, DL Rubin, DW Blayney, ...","BMJ open 9 (7), e027182",,0,2019
Registration of prostate MRI and whole mount histology images in prostate cancer patients,"M Rusu, C Kunder, N Teslovich, R Sood, R Fan, P Ghanouni, R West, ...",arXiv preprint arXiv:1907.00324,,0,2019
Applying the PRECISION approach in biopsy naïve and previously negative prostate biopsy patients,"NN Wang, NC Teslovich, RE Fan, P Ghanouni, JT Leppert, JD Brooks, ...",Urologic Oncology: Seminars and Original Investigations,,0,2019
PD50-01 ASSESSMENT OF MRI PERFORMANCE IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS),"M Liss*, M Garcia, Y Zheng, L Newcomb, C Filson, H Boyer, J Brooks, ...","The Journal of Urology 201 (Supplement 4), e911-e912",,0,2019
MP48-15 EVALUATION OF POTENTIAL BIAS IN RISK FACTOR ASSESSMENT IN THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS),"L Newcomb*, Y Zheng, A Faino, J Schenk, J Brooks, M Cooperberg, ...","The Journal of Urology 201 (Supplement 4), e703-e703",,0,2019
MP41-19 OPTIMIZING LIFE EXPECTANCY ESTIMATES FOR VHA PATIENTS WITH PROSTATE CANCER,"E Sohlberg*, IC Thomas, T Daskivich, T Skolarus, J Shelton, D Makarov, ...","The Journal of Urology 201 (Supplement 4), e604-e604",,0,2019
PD60-05 AUTOMATED DETECTION OF PROSTATE CANCER ON MULTIPARAMETRIC MRI USING DEEP NEURAL NETWORKS TRAINED ON SPATIAL COORDINATES AND PATHOLOGY OF BIOPSY CORES,"L Chen*, N Bien, R Fan, R Cheong, P Rajpurkar, A Thong, N Wang, ...","The Journal of Urology 201 (Supplement 4), e1098-e1098",,0,2019
PD50-10 AFRICAN AMERICAN RACE IS NOT ASSOCIATED WITH RECLASSIFICATION DURING ACTIVE SURVEILLANCE: RESULTS FROM THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS),"JM Schenk, AV Faino, LF Newcomb*, JD Brooks, PR Carroll, A Dash, ...","The Journal of Urology 201 (Supplement 4), e916-e916",,0,2019
MP31-12 THE ALBUMIN-CREATININE RATIO AND KIDNEY FUNCTION OUTCOMES AFTER NEPHRECTOMY,"A Sun*, IC Thomas, C Ganesan, A Pao, T Wagner, J Brooks, G Chertow, ...","The Journal of Urology 201 (Supplement 4), e436-e437",,0,2019
Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active …,"DW Lin, Y Zheng, J McKenney, M Brown, R Lu, M Crager, H Boyer, ...","Journal of Clinical Oncology 37 (7_suppl), 262-262",,0,2019
"Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction","L Yu, L Zhou, Q Li, S Li, X Luo, C Zhang, B Wu, JD Brooks, H Sun","Journal of pediatric urology 15 (1), 44. e1-44. e7",,0,2019
Extracting Patient-Centered Outcomes from Clinical Notes in Electronic Health Records: Assessment of Urinary Incontinence After Radical Prostatectomy,"D Gori, I Banerjee, BI Chung, M Ferrari, P Rucci, DW Blayney, JD Brooks, ...",eGEMs 7 (1),,0,2019
Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies,"L Xu, JR Lee, S Hao, XB Ling, JD Brooks, SX Wang, SS Gambhir",PloS one 14 (8),,0,2019
Analysis of Released N-Glycans and Glycopeptide Profiling of Prostate Cancer Tissue,"SM Totten, A Bermudez, A Guerrero, J Yan, A Jones, JD Brooks, SJ Pitteri","GLYCOBIOLOGY 28 (12), 1056-1056",,0,2018
Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population,"DY Lichtensztajn, JT Leppert, JD Brooks, SA Shah, W Sieh, BI Chung, ...","Journal of the National Comprehensive Cancer Network 16 (11), 1353-1360",,0,2018
"Re: Brandon A. Mahal, David D. Yang, Natalie Q. Wang, et al. Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer. Eur Urol 2018 …","JT Leppert, JD Brooks","European urology 74 (5), e110",,0,2018
Methionine aminopeptidase II (MetAP2) activated in situ self-assembly of small-molecule probes for imaging prostate cancer.,"J Xie, M Rice, Y Cheng, G Song, C Kunder, JD Brooks, T Stoyanova, ...","CANCER RESEARCH 78 (16), 115-116",,0,2018
Defining new drivers of castration-resistant prostate cancer,"E Hsu, M Rice, R Nolley, A Bermudez, J Huang, D Peehl, C Kunder, ...","CANCER RESEARCH 78 (16), 90-90",,0,2018
Mechanism and Treatment of Renal Fibrosis: Identification of transcripts associated with renal damage due to ureteral obstruction as candidate urinary biomarkers,"B Wu, X Gong, WA Kennedy, JD Brooks","American Journal of Physiology-Renal Physiology 315 (1), F16",,0,2018
N-linked glycosylation site mapping in prostate cancer and matched normal tissue: Defining glycan microheterogeneity,"SM Totten, C Tanimoto, A Bermudez, A Hembree, JD Brooks, SJ Pitteri","Cancer Research 78 (13 Supplement), 5662-5662",,0,2018
Incidence and survival trends of de-novo metastatic prostate cancer-a population-based analysis of two national cohorts from USA and Denmark,"JT Helgstrand, M Røder, N Klemann, B Toft, D Lichtensztajn, J Brooks, ...","European Urology Supplements 17 (2), e383-e384",,0,2018
Practice-based evidence for factors associated with urinary incontinence following prostate cancer care.,"K Li, CJ Magnani, S Bozkurt, T Seto, DW Blayney, JD Brooks, ...","Journal of Clinical Oncology 36 (6_suppl), 106-106",,0,2018
When can active surveillance be less active? Prediction of long-term nonreclassification for men with low-risk prostate cancer.,"MR Cooperberg, AV Faino, LF Newcomb, P Carroll, JT Kearns, JD Brooks, ...","Journal of Clinical Oncology 36 (6_suppl), 140-140",,0,2018
Identifying Cases of Metastatic Prostate Cancer Using Machine Learning on Electronic Health Records,"MG Seneviratne, JM Banda, JD Brooks, NH Shah, ...","AMIA Annual Symposium Proceedings 2018, 1498",,0,2018
1614 INCREASED EXPRESSION OF NUSAP GENE IN RECURRENT PROSTATE CANCER IS MEDIATED BY E2F,"Z Gulzar, J Brooks","JOURNAL OF UROLOGY 200 (3), e647-e647",,0,2018
459 SMOKING AND ADVERSE OUTCOMES AT RADICAL PROSTATECTOMY,"T Ngo, J Lee, J Brooks, R Nolley, M Ferrari, J Presti","JOURNAL OF UROLOGY 200 (3), e187-e187",,0,2018
MP40-03 CHANGES IN PROSTATE SPECIFIC ANTIGEN SCREENING AND PROSTATE CANCER DIAGNOSIS AFTER GUIDELINE CHANGES,"CJ Magnani, K Li, T Seto, KM McDonald, DW Blayney, JD Brooks, ...",The Journal of Urology,,0,2018
MP28-15 PREOPERATIVE KIDNEY FUNCTION TRENDS: IMPROVING ESTIMATES OF BASELINE KIDNEY FUNCTION PRIOR TO KIDNEY CANCER SURGERY,"A Sun, IC Thomas, C Ganesan, J Sylman, A Pao, T Wagner, J Brooks, ...",The Journal of Urology,,0,2018
MP28-07 RENAL FUNCTION VARIABILITY: A SIMPLE METHOD TO IDENTIFY SUBCLINICAL KIDNEY DISEASE BEFORE NEPHRECTOMY,"A Sun, IC Thomas, C Ganesan, J Sylman, A Pao, T Wagner, J Brooks, ...",The Journal of Urology,,0,2018
Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance,"HG Jeon, JH Yoo, BC Jeong, SI Seo, SS Jeon, HY Choi, HM Lee, ...","PLoS ONE 12 (11), e0186026",,0,2017
Aberrant glycoprotein expression in recurrent and non-recurrent prostate cancer tissue,"SM Totten, C Tanimoto, A Bermudez, A Hembree, JD Brooks, SJ Pitteri","Cancer Research 77 (13 Supplement), 2213-2213",,0,2017
Mass spectrometric imaging of prostate biopsy samples: Cancer margin assessment from the distribution of small metabolites and lipids,"S Banerjee, RN Zare, R Tibshirani, C Kunder, R Nolley, R Fan, JD Brooks, ...",ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253,,0,2017
THE ROLE OF SURVEILLANCE BIOPSY WITH NO CANCER AS A PROGNOSTIC MARKER FOR RECLASSIFICATION: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS),"J Kearns, A Faino, L Newcomb, J Brooks, P Carroll, A Dash, W Ellis, ...","JOURNAL OF UROLOGY 197 (4), E557-E557",,0,2017
The CPC risk calculator app: A validated tool to predict recurrence after radical prostatectomy.,"MA Røder, KD Berg, MD Loft, TA Gerds, M Ferrari, FB Thomsen, ...","European Urology Supplements 16 (3), e1874-e1878",,0,2017
Improved survival in patients diagnosed with metastatic prostate cancer–a nationwide analysis,"JT Helgstrand, N Klemann, B Toft, B Vainer, K Brasso, J Brooks, P Iversen, ...","European Urology Supplements 16 (3), e76-e77",,0,2017
Survival trends in patients diagnosed with metastatic prostate cancer: A nationwide analysis.,"J Thomas Helgstrand, N Klemann, BG Toft, B Vainer, K Brasso, JD Brooks, ...","Journal of Clinical Oncology 35 (6_suppl), 171-171",,0,2017
The use of five-alpha reductase inhibitors and their association with reclassification and pathologic outcomes in the Canary Prostate Active Surveillance Study (PASS).,"JT Kearns, AV Faino, LF Newcomb, JD Brooks, P Carroll, A Dash, WJ Ellis, ...","Journal of Clinical Oncology 35 (6_suppl), 22-22",,0,2017
Trends in the incidence and survival of men diagnosed with denovo metastatic prostate cancer in the us and Denmark-a population-based analysis of two national cohorts,"JT Helgstrand, N Klemann, BG Toft, K Brasso, B Vainer, D Lichtensztajn, ...","Scandinavian Journal of Urology 51, 55-56",,0,2017
PD47-10 THE RESEARCH IMPLICATIONS OF PSA REGISTRY ERRORS,"D Guo, IC Thomas, H Mittakanti, J Shelton, D Makarov, T Skolarus, ...",The Journal of Urology,,0,2017
MP43-11 REFINED ANALYSIS OF PROSTATE SPECIFIC ANTIGEN (PSA) VELOCITY TO PREDICT OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS),"M Cooperberg, J Brooks, A Faino, Y Zheng, J Kearns, P Carroll, A Dash, ...",The Journal of Urology,,0,2017
MP39-10 INTRA-TUMOR HETEROGENEITY IN RENAL CELL CARCINOMA: IMPLICATIONS FOR PROTEOMIC ANALYSIS OF RENAL MASS BIOPSIES,"R Massoudi, C Hoerner, T Metzner, J O'Rourke, R Curtis, L Stell, C Sabatti, ...",The Journal of Urology,,0,2017
Differential methylation level of cpg loci that are determinative of a biochemical reoccurrence of prostate cancer,"RM Myers, JD Brooks, MK Kirby","US Patent App. 14/977,779",,0,2016
"Reply to being a widower may be an indication for routine prostate‐specific antigen screening above age 69 years, which the American Urological Association recommends as a …","SL Gomez, ME Martínez, JD Brooks, I Cheng, D Lichtensztajn, JD Murphy","Cancer 122 (16), 2604-2606",,0,2016
PROSTATE CANCER YIELD IN MRI LESIONS VARIES ACROSS RADIOLOGISTS: MP05-15,"G Sonn, R Fan, S Li, P Ghanouni, A Loening, B Daniel, K To'o, H Gill, ...",The Journal of Urology 195 (4),,0,2016
SYSTEMATIC EVALUATION OF LABORATORY VALUES ASSOCIATED WITH SURVIVAL IN METASTATIC RENAL CELL CARCINOMA,"J Leppert, A Golla, IC Thomas, R Lamberts, B Chung, G Sonn, S Srinivas, ...",The Journal of Urology 195 (4),,0,2016
CHANGING UTILIZATION OF PARTIAL NEPHRECTOMY: ARE AT RISK PATIENTS BEING LEFT BEHIND?,"H Mittakanti, IC Thomas, R Lamberts, G Sonn, B Chung, T Wagner, ...",The Journal of Urology 195 (4),,0,2016
Validation of Reactive Stroma as an Adverse Prognostic Factor for Gleason Grade 3+ 3= 6 and 3+ 4= 7 Prostatic Adenocarcinomas (PCA) In the Canary Retrospective Radical …,"JK McKenney, W Wei, SJ Hawley, H Auman, L Newcomb, H Boyer, L Fazli, ...","LABORATORY INVESTIGATION 96, 249A-249A",,0,2016
Differential Methylation Level of CpG Loci That Are Determinative of a Biochemical Reoccurrence of Prostate Cancer,"RM Myers, JD Brooks, MK Kirby","US Patent App. 14/774,227",,0,2016
MP05-15 PROSTATE CANCER YIELD IN MRI LESIONS VARIES ACROSS RADIOLOGISTS,"G Sonn, R Fan, S Li, P Ghanouni, A Loening, B Daniel, K To'o, H Gill, ...",The Journal of Urology,,0,2016
Differential methylation level of cpg loci that are determinative of kidney cancer,"BN Lasseigne, RM Myers, D Absher, JD Brooks","US Patent App. 14/174,542",,0,2015
Re: Nationwide prevalence of lymph node metastases in Gleason score 3+ 3= 6 prostate cancer: authors’ reply,"W Sieh, DY Lichtensztajn, SL Gomez, JJ Liu, BI Chung, I Cheng, ...","Pathology 47 (4), 394-395",,0,2015
Sexual Function/Infertility,"ML Eisenberg, S Li, JD Brooks, MR Cullen, LC Baker","diabetes 250, 250.93",,0,2015
CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS); A DESIGN OF A MULTI-INSTITUTIONAL ACTIVE SURVEILLANCE COHORT: Pl. 5.10,"L Fazli, L Newcomb, J Brooks, P Carrol, Z Feng, M Gleave, P Nelson, ...",International Journal of Urology 21,,0,2014
IQGAP1 EXPRESSION AND SURVIVAL IN CLEAR CELL RENAL CELL CARCINOMA: MP29-06,"P Barbosa, O Hammam, R Nolley, T Metzner, A Fan, S Srinivas, D Peehl, ...",The Journal of Urology 191 (4),,0,2014
Reply: To PMID 24529583.,"JT Leppert, J Hanley, TH Wagner, BI Chung, JD Brooks, S Srinivas, ...","Urology 83 (4), 779",,0,2014
MP29-06 IQGAP1 EXPRESSION AND SURVIVAL IN CLEAR CELL RENAL CELL CARCINOMA,"P Barbosa, O Hammam, R Nolley, T Metzner, A Fan, S Srinivas, D Peehl, ...",The Journal of Urology,,0,2014
MP78-20 OVERALL SURVIVAL AMONG LOW-RISK PROSTATE CANCER PATIENTS TREATED IN THE VA HEALTH CARE SYSTEM,"P Barbosa, IC Thomas, B Chung, S Srinivas, T Wagner, J Brooks, ...",The Journal of Urology,,0,2014
AN ENVIRONMENT-WIDE ASSOCIATION STUDY (EWAS) ON PROSTATE CANCER,"J Lee, C Patel, J Brooks, J Leppert",The Journal of Urology 189 (4),,0,2013
PIVOT and the challenges of localized prostate cancer care,"AE Weinberg, JD Brooks","Translational Andrology and Urology 1 (3), 141",,0,2012
Performance Characteristics of Prostate-specific Antigen in Patients Undergoing Radical Prostatectomy,"JJ Liu, M Ferrari, R Nolley, JD Brooks, JC Presti Jr","Urology 79 (6), 1336-1339",,0,2012
Treatment and mortality in men with localized prostate cancer: A population-based study in California,"W Sieh, DY Lichtensztajn, DO Nelson, M Cockburn, DW West, JD Brooks, ...","Cancer Research 72 (8 Supplement), 5513-5513",,0,2012
459 SMOKING AND ADVERSE OUTCOMES AT RADICAL PROSTATECTOMY,"T Ngo, J Lee, J Brooks, R Nolley, M Ferrari, J Presti",The Journal of Urology,,0,2011
High-throughput genetic and expression analysis of circulating tumor cells,"AAH Talasaz, G Cann, Z Gulzar, J Chen, C April, B Klotzle, M Tat, R Li, ...","Cancer Research 70 (8 Supplement), 1144-1144",,0,2010
Adjuvant Docetaxel and Abbreviated Androgen Deprivation Therapy in Patients with High Risk Prostate Cancer,"JG Bazan, CR King, JD Brooks, S Srinivas","Open Prostate Cancer Journal 3, 99-104",,0,2010
ALTERATION OF GENE EXPRESSION SIGNATURES OF CORTICAL DIFFERENTIATION AND WOUND RESPONSE IN LETHAL CONVENTIONAL RENAL CELL CARCINOMAS,"JD Brooks, H Zhao, Z Ma, R Tibshirani, JP Higgins, B Ljungberg",The Journal of Urology,,0,2009
Do cancer index and tumor volume predict prostate cancer specific death?,"TV Tarin, BI Chung, JD Brooks",The Journal of Urology,,0,2008
Natural history of positive urinary cytology after radical cystectomy-Editorial comment,JD Brooks,"JOURNAL OF UROLOGY 176 (5), 2005-2005",,0,2006
North American white mitochondrial haplogroups in prostate and renal cancer-Comment,JD Brooks,"JOURNAL OF UROLOGY 175 (2), 472-473",,0,2006
Molecular aspects of chemoprevention of prostate cancer,JD Brooks,"Prostate Cancer: Principles and Practice, 201",,0,2006
1576: Reliability of Small Amounts of Cancer in Prostate Biopsies to Reveal True Pathologic Grade–Implications for Radiation Therapy Patients,"CR King, JE McNeal, H Gill, JD Brooks, S Srinivas, JC Presti",The Journal of Urology,,0,2006
The application of genomic and proteomic approaches to human prostate cancer in developing diagnostic and prognostic markers,JD Brooks,"Urologic Oncology: Seminars and Original Investigations 3 (24), 222-223",,0,2006
399: Different Effects of Methylseleninic Acid and Selenomethionine on the Transcriptional Programs of Prostate Cancer Cells,"H Zhao, JD Brooks",The Journal of Urology,,0,2005
401: Mechanisms of Action of Sulforaphane: A Putitutive Prostate Cancer Preventive Agent,"S Bhamre, P Vince, H Zhao, JD Brooks",The Journal of Urology,,0,2005
1672: Positive Family History of Prostate Cancer is Not Associated with Worse Outcomes After Radical Prostatectomy,"KL Lee, JB Marotte, M Ferrari, JE McNeal, JD Brooks, JC Presti",The Journal of Urology,,0,2005
Normal body mass index is associated with a higher prostate cancer detection rate and less favorable pathologic features in a biopsy population,"JC Presti, U Lee, JD Brooks, MK Terris","JOURNAL OF UROLOGY 171 (4), 122-122",,0,2004
842: Prognostic Significance of Vascular Invasion: A Long-Term Follow-Up of 621 Radical Prostatectomy Patients,"MK Ferrari, SM Malhotra, JE McNeal, JD Brooks","The Journal of Urology 171 (4S), 222-222",,0,2004
Gene expression in the normal adult human kidney assessed by complementary DNA microarray,"JP Higgins, L Wang, N Kambham, K Montgomery, S Vogelmann, ...","LABORATORY INVESTIGATION 83 (1), 266A-266A",,0,2003
Applied Laparoscopic Anatomy: Abdomen and Pelvis,JD Brooks,"The Journal of Urology 158 (2), 681-682",,0,1997
Differentiation of Colonic Metaplasic From Adenocarcinoma of Urinary Bladder,"B LISA, MD JACOBS, D JAMES, MD BROOKS",,,0,1997
"Nutrition, lifestyle interventions and prevention","SL Chang, JD Brooks","Therapeutic Strategies, 1",,0,0
CANARY PROSTATE ACTIVE SURVEILLANCE STUDY PROTOCOL,"JD Brooks, PR Carroll, ME Gleave, DW Lin, PS Nelson, IM Thompson",,,0,0
PRIMARY TESTICULAR LYMPHOMA: ANALYSIS OF 155 CASES FROM THE VETERANS AFFAIRS CENTRAL CANCER REGISTRY: 835,"S Kimm, R Shinghal, J Liu, S Srinivas, J Brooks, J Presti, J Leppert",The Journal of Urology 183 (4),,0,0
"miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma","X Gong, H Zhao, M Saar, DM Peehl, MD Brooks, D James","Kidney Cancer, 1-14",,0,0
